It is an airborne bacteria that enters the body through the lungs. Most people who contract TB have no symptoms, only about 10% of infected people actually get symptoms. Of the people who get no symptoms, the bacteria can lie dormant in the body for years; these people may get symptoms if their immune systems become weakened due to other illnesses such as HIV.
TB can destroy the tissues of the lungs and other organs if not treated with antibiotics, it can often be fatal. There is now a new strain of TB that is drug resistant that appears in large cities from time-to-time.
tubercolusis
Injectable medicine for treating tuberculosis primarily refers to injectable forms of antibiotics used to combat the infection, particularly in cases of drug-resistant tuberculosis (TB). Common injectable agents include aminoglycosides like amikacin and capreomycin, as well as polypeptides like kanamycin. These medications are typically utilized during the intensive phase of treatment to enhance efficacy, especially when oral medications are insufficient or resistance is present. Their use is carefully monitored due to potential side effects and the need for proper dosing.